CHMP provides initial assessment of Valneva’s COVID-19 vaccine
Valneva expects to receive a positive CHMP recommendation for the conditional approval of its VLA2001 vaccine
Read More
Author: John Pinching
Community pharmacies save 20,000 lives during initial vaccination phases
Figures by National Audit Office estimate that programme prevented up to 262,000 hospitalisations
Read More
Data from first DMT-assisted clinical trial revealed
No sign of significant negative effects on anxiety and wellbeing following pioneering Small Pharma trial
Read More
Data delivery: Sanofi and GSK seek authorisation for COVID-19 vaccine
Pharma giants take major stride as vaccine shows significant increase in neutralising antibodies
Read More
Greater tolerance: Allergic reactions to COVID vaccine lower for second dose
Researchers discovered that recipients experiencing an allergic response to second COVID vaccine dose are minimal
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
